Breaking News

Trump sues BBC for $10 billion, accusing it of defamation over editing of the president's Jan. 6 speech

Just In

Program

New on FOX50 at 10: More frigid, Arctic air before mid-week warming. A look at the front that brings a warming wind to the forecast.

Novartis AG Common Stock (NY:NVS)

135.19 +2.62 (+1.98%)

Official Closing Price Updated: 7:00 PM EST, Dec 15, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,635,682
Open	133.90
Bid (Size)	131.99 (100)
Ask (Size)	136.47 (100)
Prev. Close	132.57
Today's Range	133.67 - 135.27
52wk Range	96.06 - 135.27
Shares Outstanding	N/A
Dividend Yield	2.95%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Financials ↗

December 10, 2025

Novartis (NVS) offers a reliable 3.27% dividend yield, backed by strong profitability, a healthy balance sheet, and a history of consistent payouts.

Via Chartmill

Silver Shines as Global Tariff Storm Gathers: A Safe-Haven and Strategic Imperative in 2025

December 09, 2025

As global trade tensions escalate dramatically throughout late 2024 and 2025, marked by a surge in protectionist policies and tit-for-tat tariffs, silver has emerged as a dual-threat asset: a critical...

Via MarketMinute

Performance

YTD	+39.2%	+39.2%
1 Month	+2.8%	+2.8%
3 Month	+9.6%	+9.6%
6 Month	+14.5%	+14.5%
1 Year	+38.3%	+38.3%

More News

Novartis' Investigational Drug Reports Longer Disease Control In Patients With Rare Blood Disorder ↗

December 09, 2025

Via Benzinga

Novartis Stock Softens Premarket Even As It Raises 2030 Outlook, Sales Guidance For Two Key Cancer Drugs ↗

November 20, 2025

Via Stocktwits

Big Pharma Layoff Wave Extends Into Next Year: UNH, Merck, BMS, Novartis File New WARN Notices ↗

November 20, 2025

Via Stocktwits

Can the Vanguard International High Dividend Yield Index Fund ETF Shares Outperform Again in 2026? ↗

December 07, 2025

Via The Motley Fool

Is Alnylam Pharmaceuticals a Millionaire Maker? ↗

December 07, 2025

Via The Motley Fool

Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035

December 03, 2025

Via MarketMinute

Morgan Stanley Downgrades Regeneron (REGN) to Equal-Weight, Citing Fair Valuation and Pipeline Scrutiny

December 03, 2025

Via MarketMinute

Janux Therapeutics Stock Sinks 50% After Prostate Cancer Trial Triggers Target Cuts Across Wall Street — Retail Sees A FOMO-Fueled Rebound ↗

December 02, 2025

Via Stocktwits

1 No-Brainer International Vanguard ETF to Buy Right Now for Less Than $100 ↗

November 29, 2025

Via The Motley Fool

2 High-Yielding ETFs That Can Bankroll Your Retirement for Years ↗

November 29, 2025

Via The Motley Fool

Why Novartis Stock Topped the Market Today ↗

November 25, 2025

Via The Motley Fool

FDA OKs Novartis SMA Treatment As First Gene Therapy Option For Kids, Teens And Adults ↗

November 25, 2025

Via Benzinga

Novartis Stock Rises Premarket After FDA Approves First Gene Therapy For Teens And Adults With Muscle-Weakening Disorder ↗

November 25, 2025

Via Stocktwits

NOVARTIS AG-SPONSORED ADR (NYSE:NVS): A Comprehensive Value Investment Analysis ↗

November 24, 2025

Via Chartmill

Bionique Wins Dual Golds for “Exosome + Probiotic” Breakthrough in Women’s Microbiome Health

November 21, 2025

Via Get News

European Stocks Soar as Strong Earnings Quell 'AI Bubble' Fears

November 20, 2025

Via MarketMinute

Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts ↗

November 20, 2025

Via Benzinga

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

November 20, 2025

Via Investor Brand Network

Is the Market Bullish or Bearish on Novartis AG? ↗

November 18, 2025

Via Benzinga

Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring ↗

November 17, 2025

Via Benzinga

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

November 20, 2025

From BioMedWire

Via GlobeNewswire

Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Strong Case for Dividend Investors ↗

November 17, 2025

Via Chartmill

BIOCHINA2026 – Fusion Forward: Uniting the Global Biopharma Community in Suzhou

November 15, 2025

Via Press Release Distribution Service

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?

Yes, Novartis AG Common Stock is publicly traded.

What exchange does Novartis AG Common Stock trade on?

Novartis AG Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Novartis AG Common Stock?

The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange

What is the current price of Novartis AG Common Stock?

The current price of Novartis AG Common Stock is 135.19

When was Novartis AG Common Stock last traded?

The last trade of Novartis AG Common Stock was at 12/15/25 07:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.